Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile function

Quality of Life Research

Volumn 13, Issue 2, 2004, Pages 349-359

  Torrance, G W ^a,b   Keresteci, M A ^b   Casey, R W ^c   Rosner, A J ^b   Ryan, N ^b   Breton, M C ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b i3 Global   (Canada)

^c The Male Health Centre   (Canada)

^d PFIZER INC   (United States)

Author keywords

Disease specific utility; Erectile dysfunction; Quality of life; Visual analogue scale

Indexed keywords

SILDENAFIL;

ADULT; AGED; ERECTILE DYSFUNCTION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SELF EVALUATION; VALIDATION PROCESS; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; CANADA; CLINICAL TRIALS; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SATISFACTION; PIPERAZINES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; VASODILATOR AGENTS;

EID: 1642401692     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:QURE.0000018482.71580.f2     Document Type: Review

References (19)

1. International Society for Pharmacoeconomic and Outcomes Research (ISPOR) Lexicon, 1st edn. In: Pashos CL, Klein EG, Wanke LA (eds), International Society for Pharmacoeconomics and Outcomes Research, 1998.
2. Feldman HA et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urology 1994; 151: 54-61.
3. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. NEJM 1998; 338: 1397-1404.
4. Wagner TH, Lue TF, Padma-Nathan H, et al. Cross-cultural development of a quality of life measure for men with erection difficulties. Qual Life Res 1996; 5: 443-449.
5. Rosen RC, et al. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49(6): 822-830.
6. Guyatt GH, Feeny DH, Patrick DL. Measuring health related quality of life. Ann Internal Med 1993; 118(8): 622-629.
7. Gold MR, Patrick DL, Torrance GW, et al. Identifying and valuing outcomes. In: Gold MR, Siegel JE, Russell LB, Weinstein MC (eds.), Cost-Effectiveness in Health and Medicine, New York: Oxford University Press, 1996; 82-134.
8. Torrance GW. Designing and conducting cost-utility analyses. In: Spilker B (ed.), Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven, 1996; 1105-1111.
9. Streiner DL, Norman GR. Health measurement scales: A practical guide to their development and use. Oxford University Press, Oxford, 1989.
10. Torrance GW, Feeny D, Furlong W. Visual analogue scales: Do they have a role in the measurement of preferences for health states? Med Decis Making 2001; 21: 329-334.
11. Conte HR. Development and use of self-report techniques for assessing sexual functioning: A review and critique. Arch Sex Behav 1983; 12: 555-576.
12. Anderson BL, Broffit B. Is there a reliable and valid self-report measure of sexual function? Arch Sex Behav 1988; 17: 509-525.
13. Foreman MM, Doherty PC. Experimental approaches to the development of pharmacological therapies for erectile dysfunction. In: Riley AJ, et al. (eds), Sexual Pharmacology, Oxford: Oxford Medical Publications, 1993; 87-113.
14. Bennett KJ, Torrance GW, Moran LA, et al. Health state utilities in knee replacement surgery: The development and evaluation of McKnee. J Rheum 1997; 24(9): 1796-1805.
15. Bennett KJ, Torrance GW. Measuring health state preferences and utilities: Rating scale, time trade-off and standard gamble techniques. In: Spilker B (ed.), Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 1996; 253-265.
16. Schwartz CE, Sprangers MAG. Methodological approaches for assessing response shift in longitudinal health related quality of life research. Soc Sci Med 1999; 48(11): 1531-1548.
17. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality of life instrument. In: Spiker B (ed.), Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers, 49-56.
18. Green C, Brazier J, Devenu M. Valuing health-related quality of life: A review of health state valuation techniques. Pharmacoeconomics 2000; 17(2 Feb): 151-165.
19. Revicki DA, Osoba D, Fairclough D, et al. Recommendations on health related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000; 9(8): 887-900.